Congress Small Cap Growth Retail holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Congress Small Cap Growth Fund Retail Class CSMVX
- NAV / 1-Day Return 47.53 / +1.39 %
- Total Assets 2.0B
-
Adj. Expense Ratio
1.260%
- Expense Ratio 1.250%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.00
- Turnover 34%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:53 AM GMT+0
Morningstar’s Analysis CSMVX
Will CSMVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ligand Pharmaceuticals Inc | 3.74 | 77M | Healthcare |
Brinker International Inc | 3.51 | 72M | Consumer Cyclical |
TG Therapeutics Inc | 3.44 | 71M | Healthcare |
Moog Inc Class A | 3.44 | 71M | Industrials |
Repligen Corp | 3.40 | 70M | Healthcare |
InterDigital Inc | 3.27 | 67M | Technology |
JFrog Ltd Ordinary Shares | 3.26 | 67M | Technology |
Imax Corp | 3.25 | 67M | Communication Services |
UFP Technologies Inc | 3.13 | 64M | Healthcare |
Sensient Technologies Corp | 3.09 | 63M | Basic Materials |